Shares of Calumet, Inc. (NASDAQ:CLMT – Get Free Report) have been assigned a consensus recommendation of “Hold” from the eight analysts that are currently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, three have given a hold recommendation and four have assigned a buy recommendation to the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is $20.0417.
A number of equities analysts recently issued reports on the company. Wall Street Zen cut Calumet from a “buy” rating to a “hold” rating in a report on Sunday, December 14th. Zacks Research upgraded Calumet from a “strong sell” rating to a “hold” rating in a report on Thursday, November 6th. HC Wainwright reaffirmed a “buy” rating and set a $33.00 price objective on shares of Calumet in a research note on Monday, November 10th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Calumet in a report on Monday. Finally, The Goldman Sachs Group boosted their price target on shares of Calumet from $15.00 to $20.00 and gave the company a “buy” rating in a report on Wednesday, October 22nd.
View Our Latest Stock Analysis on CLMT
Institutional Trading of Calumet
Calumet Price Performance
CLMT stock opened at $19.73 on Friday. The firm has a market cap of $1.71 billion, a PE ratio of -45.87 and a beta of 1.18. Calumet has a 12 month low of $7.68 and a 12 month high of $23.75. The firm has a 50 day simple moving average of $19.40 and a 200 day simple moving average of $17.53.
Calumet (NASDAQ:CLMT – Get Free Report) last posted its quarterly earnings results on Friday, November 7th. The oil and gas company reported ($0.21) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.30) by $0.09. The business had revenue of $1.08 billion during the quarter, compared to analyst estimates of $1.06 billion. During the same quarter last year, the firm posted ($1.18) EPS. The company’s quarterly revenue was down 2.0% compared to the same quarter last year. As a group, sell-side analysts expect that Calumet will post -3.02 earnings per share for the current year.
About Calumet
Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.
Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.
See Also
- Five stocks we like better than Calumet
- Put $1,000 into this stock by Jan 1 [Not NVDA]
- Do you know what Amazon is planning for January 1?
- Turn your “dead money” into $306+ monthly (starting this month)
- Washington prepares for war
- Strange Crystal Metal Outperforms Silicon Up to 100X
Receive News & Ratings for Calumet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet and related companies with MarketBeat.com's FREE daily email newsletter.
